您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览133 | 下载0

With the aging of society and the development of medically diagnostic techniques,the incidence and diagnosis rate of Alzheimer's disease (AD) have been increasing.However,there is no breakthrough in the treatment of AD at present.Thus,it is necessary to explore the optimal management for AD patients under the current condition.AD is characterized by multi-target mechanisms of pathogenesis and complexity of clinical symptoms,which requires more comprehensive treatment and management.Here,we elaborate of A2G plus (one or more of A to G and other plus measures) comprehensive management model for AD patients.This model is built upon 4 international authoritative guidelines,multi-target mechanisms of disease,existing therapeutic drugs and methods,and long-term clinical experiences and patient' s individual condition,and provides a new model of comprehensive treatment and management for AD patients.

作者:彭丹涛

来源:第三军医大学学报 2016 年 38卷 15期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:133 | 下载:0
作者:
彭丹涛
来源:
第三军医大学学报 2016 年 38卷 15期
标签:
阿尔茨海默病 A2G plus全面管理模式 药物治疗 免疫治疗 康复治疗 Alzheimer's disease A2G Plus comprehensive management model drug treatment immunotherapy rehabilitation therapy
With the aging of society and the development of medically diagnostic techniques,the incidence and diagnosis rate of Alzheimer's disease (AD) have been increasing.However,there is no breakthrough in the treatment of AD at present.Thus,it is necessary to explore the optimal management for AD patients under the current condition.AD is characterized by multi-target mechanisms of pathogenesis and complexity of clinical symptoms,which requires more comprehensive treatment and management.Here,we elaborate of A2G plus (one or more of A to G and other plus measures) comprehensive management model for AD patients.This model is built upon 4 international authoritative guidelines,multi-target mechanisms of disease,existing therapeutic drugs and methods,and long-term clinical experiences and patient' s individual condition,and provides a new model of comprehensive treatment and management for AD patients.